About the Authors
- Adam T. Szafran
-
Affiliation Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America
- Fabio Stossi
-
Affiliation Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America
- Maureen G. Mancini
-
Affiliation Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America
- Cheryl L. Walker
-
Affiliation Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America
- Michael A. Mancini
-
* E-mail: mancini@bcm.edu
Affiliations Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America, DeepBio, Inc., Houston, Texas, United States of America
Competing Interests
M.A.M. is a founding scientist and a board member of DeepBio, an organization that provides high throughput screening and novel monoclonal antibody production services. To ensure scientific independence, A.T.S., F.S., M.G.M. performed work as external consultants to DeepBio, Inc. There are no patents, products in development or marketed products to declare by DeepBio, Inc or the authors of this manuscript. The Valspar corporation provided investigational compounds for the project but had no influence study design or data interpretation. The commercial support does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceptualization: ATS FS CLW MAM. Data curation: ATS FS. Formal analysis: ATS. Funding acquisition: CLW MAM. Investigation: ATS FS MGM. Methodology: ATS FS MGM. Project administration: ATS MGM MAM. Resources: CLW MAM. Software: ATS. Supervision: CLW MAM. Validation: ATS FS MGM. Visualization: ATS. Writing – original draft: ATS. Writing – review & editing: ATS FS CLW MAM.